HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhijie Jiang Selected Research

7- O- (2,6- dideoxy- 2- fluorotalopyranose)adriamycinone (DFTA)

10/2019Intracellular cascade activated nanosystem for improving ER+ breast cancer therapy through attacking GSH-mediated metabolic vulnerability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhijie Jiang Research Topics

Disease

16Neoplasms (Cancer)
12/2021 - 01/2012
4Melanoma (Melanoma, Malignant)
01/2020 - 01/2017
3Breast Neoplasms (Breast Cancer)
10/2019 - 10/2012
2Neoplasm Metastasis (Metastasis)
09/2018 - 10/2012
1Infections
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Synovial Sarcoma (Synovioma)
01/2021
1Multiple Myeloma
01/2021
1Hepatocellular Carcinoma (Hepatoma)
02/2019
1Neoplasm Micrometastasis
09/2018
1Carcinoma (Carcinomatosis)
10/2012
1Inflammation (Inflammations)
01/2012

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2020 - 08/2018
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 08/2018
4RNA (Ribonucleic Acid)IBA
01/2018 - 01/2012
3Therapeutic UsesIBA
01/2020 - 08/2018
3Proteins (Proteins, Gene)FDA Link
12/2017 - 01/2012
2Peptides (Polypeptides)IBA
11/2020 - 09/2018
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2020 - 02/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2012
2Messenger RNA (mRNA)IBA
01/2017 - 01/2012
1Oxygen (Dioxygen)IBA
12/2021
1Melphalan (Alkeran)FDA LinkGeneric
01/2021
1infigratinibIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1PlatinumIBA
01/2021
1apatinibIBA
01/2020
1lonidamineIBA
01/2020
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
01/2020
1chrysinIBA
01/2020
1AcidsIBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1Superoxide DismutaseIBA
10/2019
1ferric chlorideIBA
10/2019
17- O- (2,6- dideoxy- 2- fluorotalopyranose)adriamycinone (DFTA)IBA
10/2019
1Glutathione (Reduced Glutathione)IBA
10/2019
1IronIBA
10/2019
1Estrogen ReceptorsIBA
10/2019
1Tannic AcidFDA Link
10/2019
1Drug CombinationsIBA
02/2019
1Ursolic AcidIBA
02/2019
1Durapatite (Hydroxylapatite)IBA
09/2018
1Drug CarriersIBA
08/2018
1Polysaccharides (Glycans)IBA
08/2018
1Biological ProductsIBA
08/2018
1DecitabineFDA Link
01/2018
1AntigensIBA
01/2018
1pirinixic acidIBA
01/2017
1CarcinogensIBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017
13' Untranslated Regions (3' UTR)IBA
01/2017
1VemurafenibIBA
01/2017
1Protein Kinases (Protein Kinase)IBA
01/2017
1Plasminogen Activators (Plasminogen Activator)IBA
10/2012
1Metalloproteases (Metalloproteinases)IBA
10/2012
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2012
1IntegrinsIBA
10/2012
1Plasminogen Activator Inhibitor 1IBA
10/2012
1Peptide Hydrolases (Proteases)FDA Link
10/2012
1Insulin (Novolin)FDA Link
01/2012
1MicroRNAs (MicroRNA)IBA
01/2012

Therapy/Procedure

7Therapeutics
01/2022 - 01/2017
2Immunotherapy
11/2020 - 01/2020
2Drug Therapy (Chemotherapy)
10/2019 - 08/2018
1Stem Cell Transplantation
01/2021
1Aftercare (After-Treatment)
01/2021
1Transcutaneous Electric Nerve Stimulation (TENS)
01/2021
1Lasers (Laser)
10/2019